Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A

NCT00621673 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer